Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.96M Buy
619,337
+12,508
+2% +$39.1K 1.55% 21
2026
Q1
$1.78M Sell
606,829
-192,353
-24% -$550K 1.52% 20
2025
Q4
$2.04M Buy
799,182
+35,807
+5% +$85.3K 1.76% 18
2025
Q3
$1.72M Buy
763,375
+187,364
+33% +$429K 1.61% 20
2025
Q2
$1.4M Buy
576,011
+98,420
+21% +$240K 1.79% 22
2025
Q1
$1.12M Buy
477,591
+21,443
+5% +$42.9K 1.44% 27
2024
Q4
$893K Buy
456,148
+219,666
+93% +$486K 1.12% 30
2024
Q3
$577K Hold
236,482
0.76% 35
2024
Q2
$485K Buy
236,482
+146,154
+162% +$333K 0.66% 38
2024
Q1
$224K Hold
90,328
0.36% 38
2023
Q4
$267K Sell
90,328
-18,796
-17% -$50.8K 0.45% 33
2023
Q3
$282K Hold
109,124
0.51% 40
2023
Q2
$347K Buy
+109,124
New +$321K 0.64% 34

Other funds holding ABEV

Virtus Family Office's ABEV Position: Q2 2026 in Review

Virtus Family Office increased its Ambev (ABEV) stake by 2.1% in Q2 2026, buying an estimated $39.1K and bringing the position to 619,337 shares worth $1.96M. The position accounts for 1.55% of the portfolio, ranked #21.

Virtus Family Office first reported a position in ABEV in Q2 2023 and has held it in 13 quarters since. The position peaked at $2.04M in Q4 2025. 404 funds tracked by Wall St. Rank hold ABEV as of Q2 2026.

  • Virtus Family Office held 619,337 shares of Ambev worth $1.96M as of Q2 2026.
  • Virtus Family Office bought 12,508 Ambev shares in Q2 2026, an estimated $39.1K.
  • Ambev made up 1.55% of Virtus Family Office's portfolio in Q2 2026, its #21 holding.
  • Virtus Family Office first reported a position in Ambev in Q2 2023 and has held it in 13 quarters since.
  • Virtus Family Office's Ambev position peaked at $2.04M in Q4 2025.
  • 404 funds tracked by Wall St. Rank held Ambev as of Q2 2026.

Based on Virtus Family Office's 13F filing for Q2 2026, filed 4 Aug 2026.